ACE2 and COVID-19: SARS-CoV-2 infects susceptible human cells by binding to Angiotensin-Converting Enzyme 2 (ACE2) and causes a range of clinical symptoms, which can progress to severe COVID-19 based on vaccination status and co-morbidities [1,2].